25 related articles for article (PubMed ID: 38686412)
1. Natural Compound Shikonin Is a Novel PAK1 Inhibitor and Enhances Efficacy of Chemotherapy against Pancreatic Cancer Cells.
Ji W; Sun X; Gao Y; Lu M; Zhu L; Wang D; Hu C; Chen J; Cao P
Molecules; 2022 Apr; 27(9):. PubMed ID: 35566098
[TBL] [Abstract][Full Text] [Related]
2. [Identification of potential targets and synergistic mechanism of Kushen Decoction for the treatment of cryptosporidiosis].
Zhan N; Liu XH; Tang FY; Zhang JY
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2021 Oct; 33(5):483-495. PubMed ID: 34791846
[TBL] [Abstract][Full Text] [Related]
3. Molecular modelling approaches predicted 1,2,3-triazolyl ester of ketorolac (15K) to be a novel allosteric modulator of the oncogenic kinase PAK1.
Shahinozzaman M; Ahmed S; Emran R; Tawata S
Sci Rep; 2021 Sep; 11(1):17471. PubMed ID: 34471161
[TBL] [Abstract][Full Text] [Related]
4. A computational approach to explore and identify potential herbal inhibitors for the p21-activated kinase 1 (PAK1).
Shahinozzaman M; Ishii T; Ahmed S; Halim MA; Tawata S
J Biomol Struct Dyn; 2020 Aug; 38(12):3514-3526. PubMed ID: 31448698
[TBL] [Abstract][Full Text] [Related]
5. Redesign of the PAK1 autoinhibitory domain for enhanced stability and affinity in biosensor applications.
Jha RK; Wu YI; Zawistowski JS; MacNevin C; Hahn KM; Kuhlman B
J Mol Biol; 2011 Oct; 413(2):513-22. PubMed ID: 21888918
[TBL] [Abstract][Full Text] [Related]
6. [Computer-aided prediction and molecular mechanism investigation of active components in compound Kushen injection inhibiting p21-activated kinase 1].
Lin L; Chang J; Tian Y; Chen J
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2024 Apr; 41(2):313-320. PubMed ID: 38686412
[TBL] [Abstract][Full Text] [Related]
7. The role of p21-activated kinases in pancreatic cancer.
Yeo D; He H; Baldwin GS; Nikfarjam M
Pancreas; 2015 Apr; 44(3):363-9. PubMed ID: 25760284
[TBL] [Abstract][Full Text] [Related]
8. Targeting PAK1.
Semenova G; Chernoff J
Biochem Soc Trans; 2017 Feb; 45(1):79-88. PubMed ID: 28202661
[TBL] [Abstract][Full Text] [Related]
9. Molecular pathways: targeting p21-activated kinase 1 signaling in cancer--opportunities, challenges, and limitations.
Eswaran J; Li DQ; Shah A; Kumar R
Clin Cancer Res; 2012 Jul; 18(14):3743-9. PubMed ID: 22595609
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumor activities of active ingredients in Compound Kushen Injection.
Wang W; You RL; Qin WJ; Hai LN; Fang MJ; Huang GH; Kang RX; Li MH; Qiao YF; Li JW; Li AP
Acta Pharmacol Sin; 2015 Jun; 36(6):676-9. PubMed ID: 25982630
[TBL] [Abstract][Full Text] [Related]
11. Current trends and opportunities in targeting p21 activated kinase-1(PAK1) for therapeutic management of breast cancers.
Kanumuri R; Saravanan R; Pavithra V; Sundaram S; Rayala SK; Venkatraman G
Gene; 2020 Nov; 760():144991. PubMed ID: 32717309
[TBL] [Abstract][Full Text] [Related]
12. P21-Activated Kinase 1: Emerging biological functions and potential therapeutic targets in Cancer.
Yao D; Li C; Rajoka MSR; He Z; Huang J; Wang J; Zhang J
Theranostics; 2020; 10(21):9741-9766. PubMed ID: 32863957
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
